COFCO Biotechnology Co., Ltd.
000930.SZ · SHZ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | CN¥1,909,371 | CN¥1,481,142 | CN¥1,016,637 | CN¥1,115,957 |
| Short-Term Investments | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Receivables | CN¥1,362,989 | CN¥1,123,528 | CN¥1,486,941 | CN¥1,451,951 |
| Inventory | CN¥2,769,728 | CN¥2,534,268 | CN¥3,763,200 | CN¥4,052,327 |
| Other Curr. Assets | CN¥482,655 | CN¥894,261 | CN¥282,592 | CN¥1,275,776 |
| Total Curr. Assets | CN¥6,810,032 | CN¥6,035,316 | CN¥7,670,970 | CN¥7,634,383 |
| Property Plant & Equip (Net) | CN¥8,611,625 | CN¥8,677,972 | CN¥8,612,024 | CN¥8,649,980 |
| Goodwill | CN¥366,045 | CN¥366,045 | CN¥366,045 | CN¥366,045 |
| Intangibles | CN¥602,101 | CN¥602,675 | CN¥610,575 | CN¥629,747 |
| Long-Term Investments | CN¥548,063 | CN¥535,387 | CN¥536,925 | CN¥536,569 |
| Tax Assets | CN¥280,072 | CN¥265,014 | CN¥164,548 | CN¥202,768 |
| Other NC Assets | CN¥110,901 | CN¥75,453 | CN¥139,208 | CN¥42,629 |
| Total NC Assets | CN¥10,518,807 | CN¥10,522,546 | CN¥10,429,325 | CN¥10,427,737 |
| Other Assets | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Total Assets | CN¥17,328,839 | CN¥16,557,861 | CN¥18,100,295 | CN¥18,062,120 |
| Liabilities | – | – | – | – |
| Payables | CN¥728,359 | CN¥766,492 | CN¥919,591 | CN¥920,249 |
| Short-Term Debt | CN¥3,999,752 | CN¥3,398,858 | CN¥2,874,377 | CN¥2,764,305 |
| Tax Payable | CN¥77,166 | CN¥47,591 | CN¥91,352 | CN¥64,505 |
| Deferred Revenue | CN¥0 | CN¥0 | CN¥278,732 | CN¥1,766,194 |
| Other Curr. Liab. | CN¥336,373 | CN¥206,530 | CN¥1,367,546 | CN¥139,790 |
| Total Curr. Liab. | CN¥5,836,583 | CN¥5,141,805 | CN¥5,161,513 | CN¥5,590,538 |
| LT Debt | CN¥165,099 | CN¥165,647 | CN¥191,284 | CN¥406,396 |
| Deferred Rev, NC | CN¥70,127 | CN¥0 | CN¥59,015 | CN¥50,908 |
| Deferred Tax Liab, NC | CN¥66,389 | CN¥88,999 | CN¥30,435 | CN¥32,069 |
| Other NC Liab. | CN¥97,395 | CN¥41,190 | CN¥40,920 | CN¥106,210 |
| Total NC Liab. | CN¥576,124 | CN¥492,475 | CN¥427,283 | CN¥712,885 |
| Other Liabilities | CN¥0 | CN¥70,009 | CN¥0 | CN¥0 |
| Cap. Leases | CN¥177,113 | CN¥196,638 | CN¥105,628 | CN¥117,302 |
| Total Liabilities | CN¥6,412,707 | CN¥5,704,289 | CN¥5,588,796 | CN¥6,303,423 |
| Equity | – | – | – | – |
| Pref Stock | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Common Stock | CN¥1,859,723 | CN¥1,864,721 | CN¥1,865,274 | CN¥1,865,718 |
| Retained Earnings | CN¥1,425,104 | CN¥1,411,729 | CN¥3,152,284 | CN¥2,601,346 |
| AOCI | CN¥0 | CN¥0 | CN¥1,131,480 | CN¥989,880 |
| Other Equity | CN¥1,317,337 | CN¥1,259,923 | CN¥1,174,513 | CN¥1,060,363 |
| Total Equity | CN¥10,517,912 | CN¥10,451,611 | CN¥12,099,887 | CN¥11,397,351 |
| Supplemental Information | – | – | – | – |
| Minority Interest | CN¥398,220 | CN¥401,961 | CN¥411,612 | CN¥361,346 |
| Total Liab. & Tot. Equity | CN¥17,328,839 | CN¥16,557,861 | CN¥18,100,295 | CN¥18,062,120 |
| Net Debt | CN¥2,255,481 | CN¥2,083,363 | CN¥2,049,024 | CN¥2,054,744 |